Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

Ghassan K. Abou-Alfa, Lawrence Schwartz, Sergio Ricci, Dino Amadori, Armando Santoro, Arie Figer, Jacques De Greve, Jean Yves Douillard, Chetan Lathia, Brian Schwartz, Ian Taylor, Marius Moscovici, Leonard B. Saltz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of sorafenib in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences